The goal of Health-e-Child is to become the universal biomedical knowledge repository and communication conduit for the future, a common vehicle by which all clinicians will access, analyse, evaluate, enhance and exchange biomedical data of all forms. It will be an indispensable tool in their daily clinical practice, decision making and research. It will be accessible at any time and from anywhere, and will offer a friendly, multi-modal, efficient and effective interaction and exploration environment. Pivotal to this outlook are Health-e-Child's breakthroughs in personalised medicine through integrated disease modelling, knowledge discovery and decision support.
Fashioned around three paediatric diseases with at least partly unknown causes, classification and/or treatment outcomes - heart diseases (right ventricular overload [RVO], cardiomyopathies), inflammatory diseases (juvenile idiopathic arthritis [JIA]), and brain tumours (gliomas), Health-e-Child is building the enabling tools and services that improve the quality of care and reduce its cost by increasing efficiency, through:
- Integrated disease models,
- Database-guided decision support systems,
- Cross modality information fusion and data mining for knowledge discovery.
Key to the Health-e-Child system is the establishment of multi-site, vertical, and longitudinal integration of biomedical data, information and knowledge delivered via a Gridbased platform, supported by robust tools for search, optimisation and matching processes. The core of Health-e-Child revolves around its efforts dedicated to meeting the challenges entailed in biomedical information analysis for the advancement of personalised medicine.
For further information, please visit:
http://www.Health-e-Child.org
Project co-ordinator:
Siemens AG
Partners:
- Siemens AG, Erlangen, (DE)
- Lynkeus SRL, Rome, (IT)
- I.R.C.C.S. Giannina Gaslini, Genoa, (IT)
- University College London Great Ormond Street Children's Hospital, London, (UK)
- Assistance Publique Hopitaux de Paris Necker, Paris, (FR)
- European Organisation for Nuclear Research (CERN), Geneva, (CH)
- Maat G Knowledge, Toledo, (ES)
- University of the West of England, Bristol, (UK)
- University of Athens,Athens, (GR)
- DISI University of Genoa, Genoa, (IT)
- The French National Institute for research in Computer Science and Control (INRIA), Sophia Antipolis, (FR)
- European Genetics Foundation, Bologna, (IT)
- Aktsiaselts ASPER BIOTECH, Tartu, (EE)
- Gerolamo Gaslini Foundation, Genoa, (IT)
Timetable: from 01/06 to 12/09
Total cost: 16.701.753
EC funding: 12.186.270
Instrument: IP
Project Identifier: IST-2004-027749